Comments for Cancer Immunotherapy Stocks To Watch at http://www.biomedreports.com , comment 1 to 1 out of 1 comments http://www.biomedreports.com Wed, 08 Feb 2012 18:06:24 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2009092510973/dendreon-dndn-and-the-progression-of-cancer-immunotherapy-treatments.html#comment-930 Mentor Capital is tracking a 10-stock Cancer Immunotherapy, which was initiated about two months ago: http://biomedreports.com/articles/most-popular/9741-immunocellular-otc-imucob-top-gainer-in-cancer-immunotherapy-index.html - Mike Havrilla Thu, 24 Sep 2009 23:34:13 +0100